PCa Commentary June 2021 - Treatment-Induced Neuroendocrine Prostate Cancer
This Commentary looks at the current state of causes, diagnosis and treatment for neuroendocrine prostate cancer. For more on this disease, read the commentary on GRU at: https://grandroundsinurology.com/pca-commentary-volume-154-june-2021/
Видео PCa Commentary June 2021 - Treatment-Induced Neuroendocrine Prostate Cancer канала Grand Rounds in Urology
Видео PCa Commentary June 2021 - Treatment-Induced Neuroendocrine Prostate Cancer канала Grand Rounds in Urology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Accuracy of ExactVu Micro-Ultrasound for Diagnosis of Prostate Cancer
Minimally-Invasive Management of Symptomatic Caliceal Diverticular Stones
Radiologic Perspective on the Clinical Utility of and Emerging Data on Micro-Ultrasound
Nephron-Sparing Renal Surgery: Local Recurrence Issues and Preoperative & Postoperative Decisions
PSMA PET Imaging at Time of Diagnosis
The ENGAGEMENT Study - Virtual Genetics Board for Improving Prostate Cancer Genetic Testing
Androgen Targeted Therapy Across the Continuum of Prostate Cancer
Management of Recurrent Prostate Cancer After Focal Therapy
Join us for IPCU 33 in Vail CO, January 22-25, 2023
Case Discussion: Early Detection of Prostate Cancer 2023
The Case for Standard Imaging
IPCU Session 1 Review: Men's Prostate Health
Bottom Line Shrinking? Check Your EOBs
Socioeconomic Aspects of Prostate Brachytherapy
Non-Muscle Invasive Bladder Cancer: Guidelines-Based Approach
Pathologist's Perspective on Focal Therapy
Managing a Clinical Research Program in 2020
Contemporary Management of Recurrent Idiopathic Priapism
Garnick - Review of the New Standard in Treatment and Global Issues
PSA Screening in 2023
Financial Toxicity